🇺🇸 Micardis plus 80/12.5 in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 9

Most-reported reactions

1. Amnesia — 1 report (11.11%)
2. Body Temperature Increased — 1 report (11.11%)
3. Chills — 1 report (11.11%)
4. Cytokine Release Syndrome — 1 report (11.11%)
5. Delirium — 1 report (11.11%)
6. Overdose — 1 report (11.11%)
7. Pyrexia — 1 report (11.11%)
8. Sleep Walking — 1 report (11.11%)
9. Suicidal Ideation — 1 report (11.11%)

Source database →

Frequently asked questions

Is Micardis plus 80/12.5 approved in United States?

Micardis plus 80/12.5 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Micardis plus 80/12.5 in United States?

Heart Care Foundation is the originator. The local marketing authorisation holder may differ — check the official source linked above.